36623 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Sep 15
12:19 UTC
|
CRDF
Cardiff Oncology
|
↑ Upgrade | Robert Burns ★★☆☆☆ #2773 | Neutral→ Buy | |
|
Sep 15
12:19 UTC
|
AGL
Agilon Health
|
↑ Upgrade | Lance Wilkes ★★★☆☆ #1179 | Market Perform→ Outperform | $86.00→ $125.00+45.3% |
|
Sep 15
11:19 UTC
|
WPP
WPP
|
◎ Target | firm only | Buy | GBX 405→ GBX 470+16.0% |
|
Sep 15
11:19 UTC
|
WIZZ
Wizz Air
|
◎ Target | firm only | Hold | GBX 1,200→ GBX 1,000-16.7% |
|
Sep 15
11:19 UTC
|
NWG
NatWest Group
|
◎ Target | firm only | Neutral | GBX 790→ GBX 830+5.1% |
|
Sep 15
11:19 UTC
|
LLOY
Lloyds Banking Group
|
◎ Target | firm only | Neutral | GBX 121→ GBX 123+1.7% |
|
Sep 15
11:19 UTC
|
KIST
Kistos
|
◎ Target | firm only | Buy | GBX 325→ GBX 405+24.6% |
|
Sep 15
11:19 UTC
|
GSK
GSK
|
◎ Target | firm only | Hold | GBX 2,000→ GBX 2,200+10.0% |
|
Sep 15
11:19 UTC
|
DATA
GlobalData
|
◎ Target | firm only | Neutral | GBX 110→ GBX 90-18.2% |
|
Sep 15
11:19 UTC
|
DATA
GlobalData
|
◎ Target | firm only | Buy | GBX 105→ GBX 90-14.3% |
|
Sep 15
11:19 UTC
|
CER
Cerillion
|
◎ Target | firm only | Buy | GBX 1,400→ GBX 1,200-14.3% |
|
Sep 15
11:19 UTC
|
BARC
Barclays
|
◎ Target | firm only | Overweight | GBX 610→ GBX 620+1.6% |
|
Sep 15
11:19 UTC
|
IOCJY
Iochpe-Maxion
|
↓ Downgrade | firm only | Neutral | |
|
Sep 15
11:19 UTC
|
DATA
GlobalData
|
↓ Downgrade | firm only | Buy | GBX 98→ GBX 170+73.5% |
|
Sep 15
11:19 UTC
|
ASND
Ascendis Pharma A/S
|
↓ Downgrade | firm only | Outperform | $287.00 |
|
Sep 15
11:19 UTC
|
SEIC
SEI Investments
|
↑ Upgrade | firm only | Outperform | |
|
Sep 15
11:19 UTC
|
RMD
ResMed
|
↑ Upgrade | Craig Wong-Pan ★★★★☆ #738 | Sec→ r Perform ➝ Outperform | $262.00 |
|
Sep 15
11:19 UTC
|
PNR
Pentair
|
↑ Upgrade | Nigel Coe ★★★☆☆ #2147 | Peer Perform→ Outperform | |
|
Sep 15
11:19 UTC
|
ENB
Enbridge
|
↑ Upgrade | firm only | Sec→ r Perform ➝ Outperform | |
|
Sep 15
10:18 UTC
|
HMSO
Hammerson
|
◎ Target | firm only | Buy | GBX 448→ GBX 423-5.6% |
|
Sep 15
10:18 UTC
|
AZN
AstraZeneca
|
◎ Target | firm only | Buy | £160→ £150-6.2% |
|
Sep 15
10:18 UTC
|
SRRK
Scholar Rock
|
↓ Downgrade | Etzer Darout ★★★☆☆ #964 | Overweight→ Cautious | |
|
Sep 15
10:18 UTC
|
CLLS
Cellectis
|
↓ Downgrade | firm only | Market Perform | |
|
Sep 15
10:18 UTC
|
ASND
Ascendis Pharma A/S
|
↓ Downgrade | firm only | Outperform | |
|
Sep 15
10:18 UTC
|
RMD
ResMed
|
↑ Upgrade | Craig Wong-Pan ★★★★☆ #738 | Sec→ r Perform ➝ Outperform | |
|
Sep 15
10:18 UTC
|
RLGT
Radiant Logistics
|
↑ Upgrade | firm only | Market Perform→ Outperform | |
|
Sep 15
10:18 UTC
|
ETSY
Etsy
|
↑ Upgrade | firm only | Market Perform→ Outperform | $90.00 |
|
Sep 15
10:18 UTC
|
BNTC
Benitec Biopharma
|
↑ Upgrade | firm only | Outperform | |
|
Sep 15
10:18 UTC
|
AZN
Astrazeneca
|
↑ Upgrade | firm only | Sell→ Hold | |
|
Sep 15
10:18 UTC
|
AGL
Agilon Health
|
↑ Upgrade | firm only | Outperform | $125.00 |
|
Sep 15
01:17 UTC
|
AAPL
Apple
|
◎ Target | firm only | Neutral | $290.00→ $300.00+3.4% |
|
Sep 15
00:17 UTC
|
VLO
Valero Energy
|
◎ Target | Justin Jenkins ★★★★★ #12 | Strong-Buy | $350.00→ $450.00+28.6% |
|
Sep 15
00:17 UTC
|
VLO
Valero Energy
|
◎ Target | Joe Laetsch ★★★★☆ #742 | Equal Weight | $255.00→ $411.00+61.2% |
|
Sep 15
00:17 UTC
|
TRN
Trainline
|
◎ Target | firm only | Buy | GBX 311→ GBX 333+7.1% |
|
Sep 15
00:17 UTC
|
TH
Target Hospitality
|
◎ Target | Angel Castillo ★★★☆☆ #2171 | Overweight | $22.00→ $25.00+13.6% |
|
Sep 15
00:17 UTC
|
TCS
Tecsys
|
◎ Target | firm only | Outperform | C$40.00→ C$41.00+2.5% |
|
Sep 15
00:17 UTC
|
TCS
Tecsys
|
◎ Target | firm only | Outperform | C$40.00→ C$41.00+2.5% |
|
Sep 15
00:17 UTC
|
STZ
Constellation Brands
|
◎ Target | Kaumil Gajrawala ★☆☆☆☆ #3153 | Hold | $147.00→ $135.00-8.2% |
|
Sep 15
00:17 UTC
|
SRRK
Scholar Rock
|
◎ Target | Gary Nachman ★★★☆☆ #1175 | Strong-Buy | $65.00→ $72.00+10.8% |
|
Sep 15
00:17 UTC
|
SRRK
Scholar Rock
|
◎ Target | Geoff Meacham ★★★☆☆ #1715 | Buy | $60.00→ $74.00+23.3% |
|
Sep 15
00:17 UTC
|
SPRO
Spero Therapeutics
|
◎ Target | Raghuram Selvaraju not yet tracked | Buy | $5.00→ $6.00+20.0% |
|
Sep 15
00:17 UTC
|
SPCX
SpaceX
|
◎ Target | Julie Zhu not yet tracked | Neutral | $131.00→ $142.00+8.4% |
|
Sep 15
00:17 UTC
|
SM
SM Energy
|
◎ Target | Peyton Dorne ★★★★☆ #474 | Buy | $36.00→ $48.00+33.3% |
|
Sep 15
00:17 UTC
|
SGRY
Surgery Partners
|
◎ Target | Benjamin Rossi ★★★★★ #110 | Neutral | $14.00→ $15.00+7.1% |
|
Sep 15
00:17 UTC
|
RWT
Redwood Trust
|
◎ Target | Bose George ★★☆☆☆ #2635 | Outperform | $5.50→ $4.75-13.6% |
|
Sep 15
00:17 UTC
|
RRC
Range Resources
|
◎ Target | Josh Silverstein ★★★☆☆ #2196 | Neutral | $44.00→ $49.00+11.4% |
|
Sep 15
00:17 UTC
|
RBLX
Roblox
|
◎ Target | Ken Gawrelski ★★★★☆ #952 | Overweight | $46.00→ $64.00+39.1% |
|
Sep 15
00:17 UTC
|
RBLX
Roblox
|
◎ Target | Omar Dessouky ★★★★☆ #636 | Neutral | $44.00→ $48.00+9.1% |
|
Sep 15
00:17 UTC
|
RBLX
Roblox
|
◎ Target | Alicia Reese ★★★☆☆ #2038 | Neutral | $40.00→ $48.00+20.0% |
|
Sep 15
00:17 UTC
|
RBA
RB Global
|
◎ Target | firm only | Sec→ r Outperform | $133.00→ $130.00-2.3% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.